ARCHIVES

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

This article is from The Cancer Letter archive.

Vol. 33 No. 02 | January 19, 2007

Download PDF Visit The Full Archive

Related Articles

Skipper’s Impact: Drugs Curing 40,000 a Year

March 27, 1981

Subcommittee chairman Critical Of DCR For Lack Of “Game Plan”

October 28, 1977

The President’s Cancer Panel publishes its annual report

May 6, 2011

Cancer Education Applications Suspended Pending Restructuring

March 21, 1986

NCI Plans To Expand CTSU Management Of Clinical Trials.

February 24, 2006

NCI Lists Projected Grant Paylines

February 16, 1996